Clinical and Patient-Reported Outcomes of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) In Patients with Multiple Sclerosis: (Mainly focused on SPMS, RRMS) Single Center Experience
Autologous hematopoietic stem cell transplantation with low-intensity conditioning regimens in relapsing remitting multiple sclerosis: clinical outcomes and quality of life
Intermediate-Intensity Chemotherapy (IDCT) + AHSCT for patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
Indications and Efficacy of Disease-Modifying Therapies and Supportive Care of Multiple Sclerosis
Research Article: Acta Scientific Neurology (ASNE) Volume 8 Issue 11 November 2025
Comparison of HSCT treatment protocols available to foreign citizens